Literature DB >> 28424995

The emergence of vancomycin-resistant Staphylococcus aureus in an intensive care unit in Kerman, Iran.

Yasser Fasihi1, Fereshteh Saffari2, Shahla Mansouri2, Davood Kalantar-Neyestanaki3.   

Abstract

Methicillin-resistant Staphylococcus aureus (MRSA) is a global threat to public health. This study is the first report of the emergence of vancomycin-resistant MRSA in Kerman, Iran. During a period of 15 months, a total of 205 clinical isolates of S. aureus were collected from three university hospitals affiliated with the Kerman University of Medical Science, Kerman, Iran. Screening of methicillin and vancomycin resistance was carried out by phenotypic methods. The resistance and virulence genes of vancomycin-resistant isolates were detected by polymerase chain reaction (PCR). Staphylococcal cassette chromosome mec (SCCmec) and spa typing were used for molecular typing of vancomycin-resistant isolates. Two S. aureus isolates were considered vancomycin-resistant by phenotypic and genotypic methods. Both isolates showed a minimum inhibitory concentration (MIC) ≥ 64 µg/ml and belonged to SCCmec III and spa type t030. Finding vancomycin-resistant S. aureus (VRSA) isolates represents a serious problem. More stringent infection control policies are recommended to prevent transmission of such life-threatening isolates in the hospital setting.

Entities:  

Keywords:  Methicillin-resistant Staphylococcus aureus (MRSA); Spa type; Staphylococcal cassette chromosome mec (SCCmec); Staphylococcus aureus; Vancomycin-resistant Staphylococcus aureus (VRSA)

Mesh:

Substances:

Year:  2017        PMID: 28424995     DOI: 10.1007/s10354-017-0562-6

Source DB:  PubMed          Journal:  Wien Med Wochenschr        ISSN: 0043-5341


  17 in total

1.  A new multiplex PCR for easy screening of methicillin-resistant Staphylococcus aureus SCCmec types I-V.

Authors:  K Boye; M D Bartels; I S Andersen; J A Møller; H Westh
Journal:  Clin Microbiol Infect       Date:  2007-04-02       Impact factor: 8.067

2.  First case of infection with vancomycin-resistant Staphylococcus aureus in Europe.

Authors:  José Melo-Cristino; Cristina Resina; Viviana Manuel; Luís Lito; Mário Ramirez
Journal:  Lancet       Date:  2013-06-21       Impact factor: 79.321

3.  Involvement of Panton-Valentine leukocidin-producing Staphylococcus aureus in primary skin infections and pneumonia.

Authors:  G Lina; Y Piémont; F Godail-Gamot; M Bes; M O Peter; V Gauduchon; F Vandenesch; J Etienne
Journal:  Clin Infect Dis       Date:  1999-11       Impact factor: 9.079

4.  Detection of Staphylococcus aureus by polymerase chain reaction amplification of the nuc gene.

Authors:  O G Brakstad; K Aasbakk; J A Maeland
Journal:  J Clin Microbiol       Date:  1992-07       Impact factor: 5.948

5.  Epidemiology of vancomycin-resistant enterococci in children with acute lymphoblastic leukemia at two referral centers in Tehran, Iran: a descriptive study.

Authors:  A Nateghian; J L Robinson; K Arjmandi; P Vosough; A Karimi; A Behzad; M Navidnia
Journal:  Int J Infect Dis       Date:  2011-02-22       Impact factor: 3.623

Review 6.  Vancomycin-resistant Staphylococcus aureus: a new model of antibiotic resistance.

Authors:  K Hiramatsu
Journal:  Lancet Infect Dis       Date:  2001-10       Impact factor: 25.071

Review 7.  Staphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management.

Authors:  Steven Y C Tong; Joshua S Davis; Emily Eichenberger; Thomas L Holland; Vance G Fowler
Journal:  Clin Microbiol Rev       Date:  2015-07       Impact factor: 26.132

8.  Meticillin-resistant Staphylococcus aureus control in an intensive care unit: a 10 year analysis.

Authors:  E Raineri; L Crema; A De Silvestri; A Acquarolo; F Albertario; G Carnevale; N Latronico; N Petrosillo; C Tinelli; A Zoncada; A Pan
Journal:  J Hosp Infect       Date:  2007-10-22       Impact factor: 3.926

9.  Molecular evidence for spread of two major methicillin-resistant Staphylococcus aureus clones with a unique geographic distribution in Chinese hospitals.

Authors:  Yudong Liu; Hui Wang; Na Du; Enhua Shen; Hongbin Chen; Junqi Niu; Huifen Ye; Minjun Chen
Journal:  Antimicrob Agents Chemother       Date:  2008-11-24       Impact factor: 5.191

10.  Report of the 13th vancomycin-resistant Staphylococcus aureus isolate from the United States.

Authors:  Brandi M Limbago; Alexander J Kallen; Wenming Zhu; Paula Eggers; Linda K McDougal; Valerie S Albrecht
Journal:  J Clin Microbiol       Date:  2013-12-26       Impact factor: 5.948

View more
  3 in total

1.  Global prevalence and distribution of vancomycin resistant, vancomycin intermediate and heterogeneously vancomycin intermediate Staphylococcus aureus clinical isolates: a systematic review and meta-analysis.

Authors:  Aref Shariati; Masoud Dadashi; Majid Taati Moghadam; Alex van Belkum; Somayeh Yaslianifard; Davood Darban-Sarokhalil
Journal:  Sci Rep       Date:  2020-07-29       Impact factor: 4.379

2.  Genetic characterization of two vancomycin-resistant Staphylococcus aureus isolates in Kerman, Iran.

Authors:  Mahsa Ziasistani; Mohammad Reza Shakibaie; Davood Kalantar-Neyestanaki
Journal:  Infect Drug Resist       Date:  2019-07-04       Impact factor: 4.003

3.  Systematic review and meta-analysis of the epidemiology of vancomycin-resistance Staphylococcus aureus isolates.

Authors:  Qianxing Wu; Niloofar Sabokroo; Yujie Wang; Marzieh Hashemian; Somayeh Karamollahi; Ebrahim Kouhsari
Journal:  Antimicrob Resist Infect Control       Date:  2021-06-30       Impact factor: 4.887

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.